Published in Biochem Biophys Res Commun on June 27, 2003
The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin. PLoS One (2007) 1.26
The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell. Inflamm Res (2009) 1.25
Global gene expression analyses of hematopoietic stem cell-like cell lines with inducible Lhx2 expression. BMC Genomics (2006) 0.90
Perifosine induces differentiation and cell death in prostate cancer cells. Cancer Lett (2008) 0.90
Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol (2004) 0.83
Down-regulation of NDRG1 promotes migration of cancer cells during reoxygenation. PLoS One (2011) 0.81
Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways. Mol Med Rep (2015) 0.79
Global gene expression analysis reveals a link between NDRG1 and vesicle transport. PLoS One (2014) 0.79
Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype. Immunology (2016) 0.75
Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in Ndrg1 deficient mice. Sci Rep (2016) 0.75
N-myc downstream-regulated gene 1: Diverse and complicated functions in human hepatocellular carcinoma (Review). Oncol Lett (2013) 0.75
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19
Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat (2002) 2.92
Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci (2004) 2.47
Phospholipase A2. J Biochem (2002) 1.82
Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections. J Infect Dis (2004) 1.79
ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis. Am J Physiol Renal Physiol (2010) 1.69
Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem (2003) 1.69
Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J Biol Chem (2004) 1.65
Prostaglandin E synthase. Prostaglandins Other Lipid Mediat (2002) 1.65
Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res (2004) 1.60
Prostaglandin E synthase: a novel drug target for inflammation and cancer. Curr Pharm Des (2006) 1.54
Angiogenesis in vitro: vascular tube formation from the differentiation of neural stem cells. J Pharmacol Sci (2004) 1.51
Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J Biol Chem (2003) 1.47
Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med (2009) 1.36
RalA functions as an indispensable signal mediator for the nutrient-sensing system. J Biol Chem (2008) 1.28
Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. J Biol Chem (2006) 1.25
Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem J (2004) 1.25
A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. Proc Natl Acad Sci U S A (2002) 1.23
Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun (2005) 1.22
Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J Biochem Mol Biol (2005) 1.21
Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation. Mol Biol Cell (2006) 1.21
Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J Biol Chem (2008) 1.19
Preventing C5 palsy after laminoplasty. Spine (Phila Pa 1976) (2003) 1.18
Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family. J Biol Chem (2005) 1.17
Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models. Biochimie (2010) 1.14
Transcriptome analysis of Japanese pear (Pyrus pyrifolia Nakai) flower buds transitioning through endodormancy. Plant Cell Physiol (2013) 1.12
Britanin suppresses LPS-induced nitric oxide, PGE2 and cytokine production via NF-κB and MAPK inactivation in RAW 264.7 cells. Int Immunopharmacol (2012) 1.09
Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int (2002) 1.09
Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations. J Magn Reson Imaging (2008) 1.08
Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem (2002) 1.08
Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J Exp Med (2013) 1.08
Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. Biochim Biophys Acta (2005) 1.08
Expression of secretory phospholipase A2s in human atherosclerosis development. Atherosclerosis (2007) 1.07
Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat Immunol (2013) 1.06
A new alarm point of transcranial electrical stimulation motor evoked potentials for intraoperative spinal cord monitoring: a prospective multicenter study from the Spinal Cord Monitoring Working Group of the Japanese Society for Spine Surgery and Related Research. J Neurosurg Spine (2013) 1.06
Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice. J Clin Invest (2010) 1.06
Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2). J Biol Chem (2005) 1.05
Secretory phospholipase A2. Biol Pharm Bull (2004) 1.05
Cellular arachidonate-releasing function of novel classes of secretory phospholipase A2s (groups III and XII). J Biol Chem (2003) 1.04
Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing. Biol Pharm Bull (2013) 1.03
Rat islet culture in serum-free medium containing silk protein sericin. J Hepatobiliary Pancreat Surg (2009) 1.03
Chemical constituents of the root of Dystaenia takeshimana and their anti-inflammatory activity. Arch Pharm Res (2006) 1.03
Knockout mice lacking cPGES/p23, a constitutively expressed PGE2 synthetic enzyme, are peri-natally lethal. Biochem Biophys Res Commun (2007) 1.03
Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. Biochem Pharmacol (2011) 1.01
Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation. J Infect Dis (2005) 1.01
Arachidonate release and eicosanoid generation by group IIE phospholipase A(2). Biochem Biophys Res Commun (2002) 1.00
Inhibitory constituents against cyclooxygenases from Aralia cordata Thunb. Arch Pharm Res (2005) 1.00
Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells. Biochem J (2005) 1.00
Induction of distinct sets of secretory phospholipase A(2) in rodents during inflammation. Biochim Biophys Acta (2003) 1.00
Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages. Am J Pathol (2010) 0.99
A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin. FASEB J (2006) 0.99
Contractile responses of smooth muscle cells differentiated from rat neural stem cells. J Physiol (2002) 0.99
Group VIB Ca2+-independent phospholipase A2gamma promotes cellular membrane hydrolysis and prostaglandin production in a manner distinct from other intracellular phospholipases A2. J Biol Chem (2005) 0.99
Anti-inflammatory activity of pectolinarigenin and pectolinarin isolated from Cirsium chanroenicum. Biol Pharm Bull (2008) 0.97
Regulation of cytosolic prostaglandin E synthase by phosphorylation. Biochem J (2004) 0.96
Group X phospholipase A2 is released during sperm acrosome reaction and controls fertility outcome in mice. J Clin Invest (2010) 0.96
Impaired mast cell maturation and degranulation and attenuated allergic responses in Ndrg1-deficient mice. J Immunol (2007) 0.96
Regulation of cytosolic prostaglandin E2 synthase by 90-kDa heat shock protein. Biochem Biophys Res Commun (2003) 0.95
Neuronal expression and neuritogenic action of group X secreted phospholipase A2. J Biol Chem (2005) 0.95
New phospholipase A(2) isozymes with a potential role in atherosclerosis. Curr Opin Lipidol (2003) 0.95
Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle. Br J Pharmacol (2013) 0.94
Effects of sophoraflavanone G, a prenylated flavonoid from Sophora flavescens, on cyclooxygenase-2 and in vivo inflammatory response. Arch Pharm Res (2002) 0.94
Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis. Biochem J (2009) 0.93
Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells. FEBS J (2005) 0.93
Flowers of Inula japonica Attenuate Inflammatory Responses. Immune Netw (2010) 0.93
Induction of cytokines by toxins that have an identical RNA N-glycosidase activity: Shiga toxin, ricin, and modeccin. Biochim Biophys Acta (2004) 0.92
Biochemical pharmacology of biflavonoids: implications for anti-inflammatory action. Arch Pharm Res (2008) 0.92
Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway. J Biol Chem (2005) 0.92
Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses. Phytother Res (2002) 0.91
Effect of the silk protein sericin on cryopreserved rat islets. J Hepatobiliary Pancreat Sci (2012) 0.91
Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. Kidney Int (2002) 0.91
Localization of various secretory phospholipase A2 enzymes in male reproductive organs. Biochim Biophys Acta (2004) 0.91
Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation. Biochem J (2009) 0.91
Stabilization of mast cells by heme oxygenase-1: an anti-inflammatory role. Am J Physiol Heart Circ Physiol (2002) 0.90
Antiinflammatory activity of Synurus deltoides. Phytother Res (2004) 0.90
m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis. Circulation (2011) 0.90
Pimaric acid from Aralia cordata has an inhibitory effect on TNF-α-induced MMP-9 production and HASMC migration via down-regulated NF-κB and AP-1. Chem Biol Interact (2012) 0.90
The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells. Arch Biochem Biophys (2006) 0.90